Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 92

Results For "Europe"

971 News Found

GSK Consumer Health launch first carbon-neutral toothbrush
Sustainability | September 07, 2021

GSK Consumer Health launch first carbon-neutral toothbrush

In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia


Brinton launches Hohner Health in India
Healthcare | September 06, 2021

Brinton launches Hohner Health in India

The focus is on wellness and personal care products


Medtech player Healthium acquires CareNow
Packaging | September 02, 2021

Medtech player Healthium acquires CareNow

This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK


Zymo Research receives CE Mark for new Covid-19 SafeCollect kits
Drug Approval | September 01, 2021

Zymo Research receives CE Mark for new Covid-19 SafeCollect kits

Self-collection devices designed for ease of use and safety


DCGI approves Enzene biosimilar Denosumab for Osteoporosis
Drug Approval | August 28, 2021

DCGI approves Enzene biosimilar Denosumab for Osteoporosis

This is Enzene Biosciences third biosimilar to be approved


Japan approves AstraZeneca’s Forxiga for chronic kidney disease
Drug Approval | August 28, 2021

Japan approves AstraZeneca’s Forxiga for chronic kidney disease

Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options


Pfizer and BioNTech initiate rolling submission for Comirnaty booster dose
Drug Approval | August 26, 2021

Pfizer and BioNTech initiate rolling submission for Comirnaty booster dose

The submission to the US FDA has been initiated and they intend to file these data with the European Medicines Agency and other regulatory bodies in the coming weeks


Johnson & Johnson booster dose indicate impressive results
Drug Approval | August 26, 2021

Johnson & Johnson booster dose indicate impressive results

New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.


Regimen launches world’s first personalised digital therapy for ED
Startup | August 25, 2021

Regimen launches world’s first personalised digital therapy for ED

The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe


Carbogen Amcis AG signs co-investment agreement
Biotech | August 25, 2021

Carbogen Amcis AG signs co-investment agreement

The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound